With an aging population, improvement in life expectancy, and significant increase in the use
of bioprosthetic valves, structural valve deterioration will become more and more prevalent. …

Cardiovascular disease (CVD) continues to be one of the main causes of death in the western
world. A high burden of disease and the high costs for the healthcare systems claim for …

Objectives : The aim of this study was to evaluate the use of transcatheter heart valves (THV)
for the treatment of noncalcific pure native aortic valve regurgitation (NAVR) and failing …

There is a paucity of data describing acute kidney injury (AKI) following transcatheter aortic
valve implantation and its impact on mortality remains unknown. We therefore evaluate the …

Aims: We sought to determine the long-term outcome of high-risk patients who underwent
transcatheter aortic valve replacement (TAVR) with first-generation devices with a focus on the …

Aims Targeting vascular inflammation represents a novel therapeutic approach to reduce
complications of atherosclerosis. Neutralizing the pro-inflammatory cytokine interleukin-1β (IL-…

Rationale: Direct reprogramming of fibroblasts into cardiomyocytes is a novel strategy for
cardiac regeneration. However, the key determinants involved in this process are unknown. …

The heart is a central human organ and its diseases are the leading cause of death worldwide,
but an in-depth knowledge of the identity and quantity of its constituent proteins is still …

Background : Limited data exist about safety and efficacy of transcatheter aortic valve
replacement (TAVR) in patients with pure native aortic regurgitation (AR). Objectives : This study …

Fibroblasts are cells with a structural function, synthesizing components of the extracellular
matrix. They are accordingly associated with various forms of connective tissue. During …